Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,745 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07521631RecruitingPhase 2
HDM1005 versus Tirzepatide for weight management in obese adults
This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.
ShanghaiAges 18–65 - NCT07521007RecruitingPhase 2
YN001 treatment for coronary artery disease
This study tests whether a new drug called YN001 can help people with coronary atherosclerosis (narrowing of heart blood vessels). The trial aims to see if it can improve outcomes in people who have early-stage blockages in their heart arteries.
Huntsville, AlabamaAges 18–80 - NCT07520006RecruitingPhase 1/Phase 2
NX-5948 With Other Drugs for B-cell Blood Cancers
This early-stage study tests a new drug called NX-5948, given alongside other cancer treatments, for adults with B-cell lymphomas and leukemias (including chronic lymphocytic leukemia, or CLL). The goal is to see if this combination helps control the disease, especially in patients whose cancer has come back or stopped responding to prior treatments.
Aurora, ColoradoAges 18 years+ - NCT07522099RecruitingPhase 2
Study of ADARx Treatment for Kidney Disease in Chinese Adults
This study tests a new ADARx medicine in Chinese adults with specific types of kidney disease (IgAN, C3G, or IC-MPGN). The goal is to see if this treatment can slow kidney damage and help preserve kidney function.
Shenzhen, GuangdongAges 18 years+ - NCT07517250Recruiting
Study of Canakinumab for Fever and Joint Disease
This is a study looking back at patients who were already treated with a medicine called canakinumab for familial Mediterranean fever or Still's disease (rare conditions that cause fevers and joint pain). Researchers want to understand how well this medicine worked over time and what happened to patients who took it.
BaselAges 1 year+ - NCT07516873Recruiting
Mindfulness and Nerve Stimulation for Young Adults Drinking Heavily
This study tests whether brief mindfulness training combined with a mild electrical stimulation device on the ear can help reduce cravings and urges to drink alcohol in people aged 21–29 who drink heavily. The goal is to understand if this combination approach works better than either alone.
Malden, MassachusettsAges 21–29 - NCT07516301Recruiting
Substance use screening for adult childhood cancer survivors
This study tests whether adding a quick substance use survey and a short follow-up conversation into your regular clinic visits is helpful. It is designed for people who were treated for childhood cancer and are now adults.
Memphis, TennesseeAges 15 years+ - NCT07521189Recruiting
How Diet Type Affects Protein Digestion in Young and Older Adults
This study compares how well the body digests protein from plant-based versus meat-based diets in young adults (18–23) and older adults (65–75). Researchers want to understand if age and diet type affect how efficiently your body uses protein from food.
BobignyAges 18–75 - NCT07523672Enrolling by invitation
Care Model for Sarcopenic Obesity in Older Adults
This trial tests a new care approach for older adults who have both excess body fat and muscle loss (sarcopenic obesity). The goal is to help improve muscle strength, physical function, and body composition.
Nakhon Nayok, Changwat Nakhon NayokAges 60 years+ - NCT07524478Recruiting
Smartphone app with AI to help healthy older adults stay active
This study tests a smartphone app powered by artificial intelligence (AI) that combines exercise, cognitive activities, and health tracking through a Fitbit wearable device. It aims to see if personalized recommendations delivered on your phone can help healthy older adults maintain or improve their physical and mental wellness.
Kashiwa, ChibaAges 65–93 - NCT07518875Enrolling by invitation
Online weight loss program for Arab adults
This study tests an online dietary weight loss program designed for Arabic-speaking adults. You'll receive 12 educational sessions over 6 months to help manage weight and improve health conditions like diabetes or high blood pressure.
Mecca, Mecca RegionAges 18–75 - NCT07520084Recruiting
Understanding Climate Change Health Effects in Older Adults
This study explores how older adults understand climate change and its health effects. Researchers want to learn what helps or prevents people 65+ from staying informed about climate-related health risks.
Denizli, CenterAges 65 years+ - NCT07523399Recruiting
Joint Health and Balance in Adults with Hemophilia A
This study looks at how hemophilia A affects joint health, balance, and quality of life in adults. Researchers will assess your joints and balance to understand the relationship between joint damage and everyday function.
VanAges 18–65 - NCT07521371Enrolling by invitation
Intranasal Insulin for Autism in Children and Young Adults
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
Spring, TexasAges 4–21 - NCT07523048RecruitingPhase 2
Dextromethorphan-Bupropion for Moderate-to-Severe Depression
This study tests a combination medication (dextromethorphan plus bupropion) to see how it affects brain activity in people with moderate-to-severe depression. Researchers use brain imaging (fMRI) to understand how the drug works and whether it may help relieve depression symptoms.
Toronto, OntarioAges 18–65 - NCT07518407Recruiting
Nutrition Education and Diet Guidance While Using GLP-1 Medication
This study teaches adults on GLP-1 medication (like Ozempic or Wegovy) how to eat better and lose weight using a smartphone app. Researchers want to see if personalized nutrition advice helps you get better results from your medication.
Columbia, South CarolinaAges 18–65 - NCT07517809Recruiting
Comparing two nerve-block techniques for arm surgery
This trial compares two different ultrasound-guided methods of numbing the nerves in your upper arm and shoulder for surgery on your hand, wrist, or forearm. The goal is to see which technique works better and is safer for patients.
CairoAges 21–65 - NCT07523633RecruitingPhase 2
Semaglutide to help reduce cannabis use disorder
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
FrederiksbergAges 18–70 - NCT07511205RecruitingPhase 1
Study of AZD1043 for overweight or obesity
This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.
Glendale, CaliforniaAges 18–65 - NCT07514858RecruitingPhase 2
Lu AF28996 for Parkinson's Disease Motor Fluctuations
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
Farmington Hills, MichiganAges 40–85 - NCT07515638Recruiting
Immune System Study for Autoimmune Diseases
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
MontpellierAges 18 years+ - NCT07507760RecruitingPhase 2
Oral decitabine plus ivosidenib for older AML patients
This trial tests a combination of two oral drugs (decitabine and ivosidenib) as a first treatment for older or frail adults with AML that has an IDH1 mutation. The goal is to see if this pill-only regimen is safe and effective without needing intensive chemotherapy.
AveiroAges 18 years+ - NCT07513168RecruitingPhase 4
Low-dose semaglutide for weight loss in obese adults
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
Hyderābād, SindhAges 18 years+ - NCT07508813Recruiting
Digital system to check and reduce disability risk in older adults
This study tests a digital tool that helps assess and reduce the risk of disability in older adults living in the community. It uses a smartphone app to monitor and guide personalized interventions.
Hangzhou, ZhejiangAges 65 years+
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,745 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.